On average, there were 4 IPO per month, and nearly 90 % of the companies had VC/PE support. The original investment period of 8-10 years was reduced to about 3-5 years. Total funds raised reached over 200 billion yuan. China Bio news release, November 30,...
A biomedical engineer by education, Tao XU is presently Director of the Innovation Center of Instruments and Technologies for Life Sciences at CAS Beijing Institute of Life Sciences. His focus is on membrane and vesicle transport. Born in May 1970, he was a postdoc...
Der von der Regenerative Medicine Technology Co. und der Zhejiang University entwickelte Roboter besteht aus einem kompakten halbrunden Körper und einem Flachbildschirm. Der Benutzer scannt zuerst seinen QR-Code (WeChat) am oberen Rand des Displays, um sich mit dem...
According to a CFDA law amendment brought to congress vote, certification of drugs in China might be simplified in the future: 1. permission for manufacture and GMP certificate will be combined in one certificate, and 2. permission for storage (GSP = good storage...
Cyanobacteria such as Synechococcus sp. PCC 7942 overproduce sucrose to achieve osmotolerance in saline solution. The teams around Xuefeng LU and Quan LUO at CAS Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT), in collaboration with Martin Hagemann...
This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.
Accept or Deny
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
